deltatrials
Unknown NA NCT01920789

Stereotactic Precision And Conventional Radiotherapy Evaluation

A Multicenter Randomized Phase II Study of Stereotactic Hypofractionated Radiotherapy With Body Frame Versus Conventionally Fractionated Radiotherapy for Stage I Medically Inoperable Non-small Cell Lung Cancer

Sponsor: Ass. Prof. Jan Nyman

Conditions Non-small Cell Lung Cancer
Interventions Conventionally fractionated radiotherapy Stereotactic radiotherapy
Updated 5 times since 2017 Last updated: Dec 8, 2014 Started: Jan 31, 2007 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This NA trial investigates Non-small Cell Lung Cancer and is currently ongoing. Ass. Prof. Jan Nyman leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ass. Prof. Jan Nyman
  • Göteborg University
  • Karolinska Institutet
Data source: Swedish Lung Cancer Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.